Toru Takimoto - Publications

School of Medicine and Dentistry University of Rochester, Rochester, NY 
Virology Biology, Molecular Biology

51 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Scaggs Huang F, Bernstein DI, Slobod KS, Portner A, Takimoto T, Russell CJ, Meagher M, Jones BG, Sealy RE, Coleclough C, Branum K, Dickey M, Buschle K, McNeal M, Makowski M, et al. Safety and immunogenicity of an intranasal sendai virus-based vaccine for human parainfluenza virus type I and respiratory syncytial virus (SeVRSV) in adults. Human Vaccines & Immunotherapeutics. 1-6. PMID 32750273 DOI: 10.1080/21645515.2020.1779517  0.4
2018 Chaimayo C, Dunagan M, Hayashi T, Santoso N, Takimoto T. Specificity and functional interplay between influenza virus PA-X and NS1 shutoff activity. Plos Pathogens. 14: e1007465. PMID 30496325 DOI: 10.1371/Journal.Ppat.1007465  0.32
2017 Bajimaya S, Frankl T, Hayashi T, Takimoto T. Cholesterol is required for stability and infectivity of influenza A and respiratory syncytial viruses. Virology. 510: 234-241. PMID 28750327 DOI: 10.1016/J.Virol.2017.07.024  0.32
2017 Bajimaya S, Hayashi T, Takimoto T. Rescue of Sendai Virus from Cloned cDNA. Methods in Molecular Biology (Clifton, N.J.). 1602: 103-110. PMID 28508216 DOI: 10.1007/978-1-4939-6964-7_7  0.32
2017 Chaimayo C, Hayashi T, Underwood A, Hodges E, Takimoto T. Selective incorporation of vRNP into influenza A virions determined by its specific interaction with M1 protein. Virology. 505: 23-32. PMID 28219018 DOI: 10.1016/J.Virol.2017.02.008  0.32
2016 Bajimaya S, Hayashi T, Frankl T, Bryk P, Ward B, Takimoto T. Cholesterol reducing agents inhibit assembly of type I parainfluenza viruses. Virology. 501: 127-135. PMID 27915128 DOI: 10.1016/J.Virol.2016.11.011  0.32
2016 Hayashi T, Chaimayo C, McGuinness J, Takimoto T. Critical role of the PA-X C-terminal domain of influenza A virus on its subcellular localization and shutoff activity. Journal of Virology. PMID 27226377 DOI: 10.1128/Jvi.00954-16  0.32
2015 Stone R, Hayashi T, Bajimaya S, Hodges E, Takimoto T. Critical role of Rab11a-mediated recycling endosomes in the assembly of type I parainfluenza viruses. Virology. 487: 11-18. PMID 26484934 DOI: 10.1016/J.Virol.2015.10.008  0.6
2015 Hayashi T, Chaimayo C, Takimoto T. Impact of influenza PA-X on host response. Oncotarget. 6: 19364-5. PMID 26305985 DOI: 10.18632/Oncotarget.5127  0.32
2015 Hayashi T, Wills S, Bussey KA, Takimoto T. Identification of influenza A virus PB2 Residues involved in enhanced polymerase activity and virus growth in mammalian cells at low temperatures Journal of Virology. 89: 8042-8049. PMID 26018156 DOI: 10.1128/Jvi.00901-15  0.6
2015 Hayashi T, MacDonald LA, Takimoto T. Influenza A Virus Protein PA-X Contributes to Viral Growth and Suppression of the Host Antiviral and Immune Responses. Journal of Virology. 89: 6442-52. PMID 25855745 DOI: 10.1128/Jvi.00319-15  0.6
2015 Zhan X, Slobod KS, Jones BG, Sealy RE, Takimoto T, Boyd K, Surman S, Russell CJ, Portner A, Hurwitz JL. Sendai virus recombinant vaccine expressing a secreted, unconstrained respiratory syncytial virus fusion protein protects against RSV in cotton rats. International Immunology. 27: 229-36. PMID 25477211 DOI: 10.1093/Intimm/Dxu107  0.6
2014 Bialas KM, Bussey KA, Stone RL, Takimoto T. Specific nucleoprotein residues affect influenza virus morphology. Journal of Virology. 88: 2227-34. PMID 24335312 DOI: 10.1128/Jvi.03354-13  0.6
2013 Kobayashi H, Iwatsuki-Horimoto K, Kiso M, Uraki R, Ichiko Y, Takimoto T, Kawaoka Y. A replication-incompetent influenza virus bearing the HN glycoprotein of human parainfluenza virus as a bivalent vaccine. Vaccine. 31: 6239-46. PMID 24144478 DOI: 10.1016/J.Vaccine.2013.10.029  0.6
2013 Stone R, Takimoto T. Critical role of the fusion protein cytoplasmic tail sequence in parainfluenza virus assembly. Plos One. 8: e61281. PMID 23593451 DOI: 10.1371/Journal.Pone.0061281  0.44
2013 Fouchier RA, García-Sastre A, Kawaoka Y, Barclay WS, Bouvier NM, Brown IH, Capua I, Chen H, Compans RW, Couch RB, Cox NJ, Doherty PC, Donis RO, Feldmann H, Guan Y, ... ... Takimoto T, et al. Transmission studies resume for avian flu. Science (New York, N.Y.). 339: 520-1. PMID 23345603 DOI: 10.1126/Science.1235140  0.6
2013 Desmet EA, Bussey KA, Stone R, Takimoto T. Identification of the N-terminal domain of the influenza virus PA responsible for the suppression of host protein synthesis. Journal of Virology. 87: 3108-18. PMID 23283952 DOI: 10.1128/Jvi.02826-12  0.76
2012 Bialas KM, Desmet EA, Takimoto T. Specific residues in the 2009 H1N1 swine-origin influenza matrix protein influence virion morphology and efficiency of viral spread in vitro. Plos One. 7: e50595. PMID 23209789 DOI: 10.1371/Journal.Pone.0050595  0.76
2012 Noronha JM, Liu M, Squires RB, Pickett BE, Hale BG, Air GM, Galloway SE, Takimoto T, Schmolke M, Hunt V, Klem E, García-Sastre A, McGee M, Scheuermann RH. Influenza virus sequence feature variant type analysis: evidence of a role for NS1 in influenza virus host range restriction. Journal of Virology. 86: 5857-66. PMID 22398283 DOI: 10.1128/Jvi.06901-11  0.6
2012 MacDonald LA, Aggarwal S, Bussey KA, Desmet EA, Kim B, Takimoto T. Molecular interactions and trafficking of influenza A virus polymerase proteins analyzed by specific monoclonal antibodies. Virology. 426: 51-9. PMID 22325937 DOI: 10.1016/J.Virol.2012.01.015  0.6
2012 Fouchier RA, García-Sastre A, Kawaoka Y, Barclay WS, Bouvier NM, Brown IH, Capua I, Chen H, Compans RW, Couch RB, Cox NJ, Doherty PC, Donis RO, Feldmann H, Guan Y, ... ... Takimoto T, et al. Pause on avian flu transmission research. Science (New York, N.Y.). 335: 400-1. PMID 22282787 DOI: 10.1126/science.335.6067.400  0.6
2012 Jones BG, Sealy RE, Rudraraju R, Traina-Dorge VL, Finneyfrock B, Cook A, Takimoto T, Portner A, Hurwitz JL. Sendai virus-based RSV vaccine protects African green monkeys from RSV infection Vaccine. 30: 959-968. PMID 22119594 DOI: 10.1016/J.Vaccine.2011.11.046  0.6
2012 Jones BG, Sealy RE, Rudraraju R, Traina-Dorge VL, Finneyfrock B, Cook A, Takimoto T, Portner A, Hurwitz JL. Corrigendum to "Sendai virus-based RSV vaccine protects African green monkeys from RSV infection" [Vaccine 30 (5) (2012) 959-968] Vaccine. 30: 6955. DOI: 10.1016/J.Vaccine.2012.09.038  0.6
2011 Aggarwal S, Dewhurst S, Takimoto T, Kim B. Biochemical impact of the host adaptation-associated PB2 E627K mutation on the temperature-dependent RNA synthesis kinetics of influenza A virus polymerase complex. The Journal of Biological Chemistry. 286: 34504-13. PMID 21816827 DOI: 10.1074/Jbc.M111.262048  0.6
2011 Bussey KA, Desmet EA, Mattiacio JL, Hamilton A, Bradel-Tretheway B, Bussey HE, Kim B, Dewhurst S, Takimoto T. PA residues in the 2009 H1N1 pandemic influenza virus enhance avian influenza virus polymerase activity in mammalian cells. Journal of Virology. 85: 7020-8. PMID 21561908 DOI: 10.1128/Jvi.00522-11  0.6
2011 Noble E, Mathews DH, Chen JL, Turner DH, Takimoto T, Kim B. Biophysical analysis of influenza A virus RNA promoter at physiological temperatures. The Journal of Biological Chemistry. 286: 22965-70. PMID 21555520 DOI: 10.1074/Jbc.M111.239509  0.6
2010 Aggarwal S, Bradel-Tretheway B, Takimoto T, Dewhurst S, Kim B. Biochemical characterization of enzyme fidelity of influenza A virus RNA polymerase complex. Plos One. 5: e10372. PMID 20454455 DOI: 10.1371/Journal.Pone.0010372  0.6
2010 Desmet EA, Hollenbaugh JA, Sime PJ, Wright TW, Topham DJ, Sant AJ, Takimoto T, Dewhurst S, Maggirwar SB. Mixed Lineage Kinase 3 deficiency delays viral clearance in the lung and is associated with diminished influenza-induced cytopathic effect in infected cells. Virology. 400: 224-32. PMID 20185156 DOI: 10.1016/J.Virol.2010.02.001  0.6
2010 Bussey KA, Bousse TL, Desmet EA, Kim B, Takimoto T. PB2 residue 271 plays a key role in enhanced polymerase activity of influenza A viruses in mammalian host cells. Journal of Virology. 84: 4395-406. PMID 20181719 DOI: 10.1128/Jvi.02642-09  0.76
2008 Bradel-Tretheway BG, Kelley Z, Chakraborty-Sett S, Takimoto T, Kim B, Dewhurst S. The human H5N1 influenza A virus polymerase complex is active in vitro over a broad range of temperatures, in contrast to the WSN complex, and this property can be attributed to the PB2 subunit. The Journal of General Virology. 89: 2923-32. PMID 19008377 DOI: 10.1099/Vir.0.2008/006254-0  0.6
2008 Zhan X, Slobod KS, Krishnamurthy S, Luque LE, Takimoto T, Jones B, Surman S, Russell CJ, Portner A, Hurwitz JL. Sendai virus recombinant vaccine expressing hPIV-3 HN or F elicits protective immunity and combines with a second recombinant to prevent hPIV-1, hPIV-3 and RSV infections. Vaccine. 26: 3480-8. PMID 18499307 DOI: 10.1016/J.Vaccine.2008.04.022  0.6
2007 Zhan X, Hurwitz JL, Krishnamurthy S, Takimoto T, Boyd K, Scroggs RA, Surman S, Portner A, Slobod KS. Respiratory syncytial virus (RSV) fusion protein expressed by recombinant Sendai virus elicits B-cell and T-cell responses in cotton rats and confers protection against RSV subtypes A and B. Vaccine. 25: 8782-93. PMID 18037543 DOI: 10.1016/J.Vaccine.2007.10.038  0.6
2007 Brown SA, Hurwitz JL, Zirkel A, Surman S, Takimoto T, Alymova I, Coleclough C, Portner A, Doherty PC, Slobod KS. A recombinant Sendai virus is controlled by CD4+ effector T cells responding to a secreted human immunodeficiency virus type 1 envelope glycoprotein. Journal of Virology. 81: 12535-42. PMID 17652379 DOI: 10.1128/Jvi.00197-07  0.6
2006 Bousse T, Takimoto T. Mutation at residue 523 creates a second receptor binding site on human parainfluenza virus type 1 hemagglutinin-neuraminidase protein. Journal of Virology. 80: 9009-16. PMID 16940513 DOI: 10.1128/Jvi.00969-06  0.4
2006 Krishnamurthy S, Takimoto T, Scroggs RA, Portner A. Differentially regulated interferon response determines the outcome of Newcastle disease virus infection in normal and tumor cell lines. Journal of Virology. 80: 5145-55. PMID 16698995 DOI: 10.1128/Jvi.02618-05  0.6
2006 Bousse T, Chambers RL, Scroggs RA, Portner A, Takimoto T. Human parainfluenza virus type 1 but not Sendai virus replicates in human respiratory cells despite IFN treatment. Virus Research. 121: 23-32. PMID 16677733 DOI: 10.1016/J.Virusres.2006.03.012  0.6
2005 Takimoto T, Hurwitz JL, Zhan X, Krishnamurthy S, Prouser C, Brown B, Coleclough C, Boyd K, Scroggs RA, Portner A, Slobod KS. Recombinant Sendai virus as a novel vaccine candidate for respiratory syncytial virus. Viral Immunology. 18: 255-66. PMID 16035938 DOI: 10.1089/Vim.2005.18.255  0.6
2005 Alymova IV, Portner A, Takimoto T, Boyd KL, Babu YS, McCullers JA. The novel parainfluenza virus hemagglutinin-neuraminidase inhibitor BCX 2798 prevents lethal synergism between a paramyxovirus and Streptococcus pneumoniae. Antimicrobial Agents and Chemotherapy. 49: 398-405. PMID 15616320 DOI: 10.1128/Aac.49.1.398-405.2005  0.4
2004 Takimoto T, Portner A. Molecular mechanism of paramyxovirus budding. Virus Research. 106: 133-45. PMID 15567493 DOI: 10.1016/J.Virusres.2004.08.010  0.4
2004 Bousse TL, Taylor G, Krishnamurthy S, Portner A, Samal SK, Takimoto T. Biological significance of the second receptor binding site of Newcastle disease virus hemagglutinin-neuraminidase protein. Journal of Virology. 78: 13351-5. PMID 15542686 DOI: 10.1128/Jvi.78.23.13351-13355.2004  0.6
2004 Takimoto T, Hurwitz JL, Coleclough C, Prouser C, Krishnamurthy S, Zhan X, Boyd K, Scroggs RA, Brown B, Nagai Y, Portner A, Slobod KS. Recombinant Sendai virus expressing the G glycoprotein of respiratory syncytial virus (RSV) elicits immune protection against RSV. Journal of Virology. 78: 6043-7. PMID 15141002 DOI: 10.1128/Jvi.78.11.6043-6047.2004  0.6
2004 Alymova IV, Taylor G, Takimoto T, Lin TH, Chand P, Babu YS, Li C, Xiong X, Portner A. Efficacy of novel hemagglutinin-neuraminidase inhibitors BCX 2798 and BCX 2855 against human parainfluenza viruses in vitro and in vivo. Antimicrobial Agents and Chemotherapy. 48: 1495-502. PMID 15105096 DOI: 10.1128/Aac.48.5.1495-1502.2004  0.4
2004 Zaitsev V, von Itzstein M, Groves D, Kiefel M, Takimoto T, Portner A, Taylor G. Second sialic acid binding site in Newcastle disease virus hemagglutinin-neuraminidase: implications for fusion. Journal of Virology. 78: 3733-41. PMID 15016893 DOI: 10.1128/Jvi.78.7.3733-3741.2004  0.4
2002 Takimoto T, Taylor GL, Connaris HC, Crennell SJ, Portner A. Role of the hemagglutinin-neuraminidase protein in the mechanism of paramyxovirus-cell membrane fusion Journal of Virology. 76: 13028-13033. PMID 12438628 DOI: 10.1128/Jvi.76.24.13028-13033.2002  0.6
2002 Bousse T, Matrosovich T, Portner A, Kato A, Nagai Y, Takimoto T. The long noncoding region of the human parainfluenza virus type 1 f gene contributes to the read-through transcription at the m-f gene junction. Journal of Virology. 76: 8244-51. PMID 12134030 DOI: 10.1128/Jvi.76.16.8244-8251.2002  0.4
2002 Connaris H, Takimoto T, Russell R, Crennell S, Moustafa I, Portner A, Taylor G. Probing the sialic acid binding site of the hemagglutinin-neuraminidase of Newcastle disease virus: identification of key amino acids involved in cell binding, catalysis, and fusion. Journal of Virology. 76: 1816-24. PMID 11799177 DOI: 10.1128/Jvi.76.4.1816-1824.2002  0.4
2001 Takimoto T, Murti KG, Bousse T, Scroggs RA, Portner A. Role of matrix and fusion proteins in budding of Sendai virus. Journal of Virology. 75: 11384-91. PMID 11689619 DOI: 10.1128/Jvi.75.23.11384-11391.2001  0.4
2001 Suzuki T, Portner A, Scroggs RA, Uchikawa M, Koyama N, Matsuo K, Suzuki Y, Takimoto T. Receptor specificities of human respiroviruses. Journal of Virology. 75: 4604-13. PMID 11312330 DOI: 10.1128/Jvi.75.10.4604-4613.2001  0.6
2000 Takimoto T, Taylor GL, Crennell SJ, Scroggs RA, Portner A. Crystallization of newcastle disease virus hemagglutinin-neuraminidase glycoprotein Virology. 270: 208-214. PMID 10772993 DOI: 10.1006/Viro.2000.0263  0.6
1998 Takimoto T, Bousse T, Coronel EC, Scroggs RA, Portner A. Cytoplasmic domain of Sendai virus HN protein contains a specific sequence required for its incorporation into virions. Journal of Virology. 72: 9747-54. PMID 9811709 DOI: 10.1128/Jvi.72.12.9747-9754.1998  0.6
1994 Hyland L, Hou S, Coleclough C, Takimoto T, Doherty PC. Mice lacking CD8+ T cells develop greater numbers of IgA-producing cells in response to a respiratory virus infection Virology. 204: 234-241. PMID 8091654 DOI: 10.1006/Viro.1994.1527  0.6
Show low-probability matches.